Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Schrodinger Inc SDGR

Technology Software - Application
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its... see more

Recent & Breaking News (NDAQ:SDGR)

Qiming's Portfolio Company InventisBio Lists on STAR Market

PR Newswire July 24, 2022

Schrödinger to Announce Second Quarter 2022 Financial Results on August 4

Business Wire July 21, 2022

Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion

PR Newswire July 10, 2022

Schrödinger Announces FDA Clearance of Investigational New Drug Application for SGR-1505, a MALT1 Inhibitor

Business Wire June 28, 2022

Schrödinger Convenes Global Educators For Second Annual Educator's Day

Business Wire June 22, 2022

Schrödinger to Present at Jefferies Healthcare Conference

Business Wire June 2, 2022

Schrödinger Announces Appointment of Arun Oberoi to Board of Directors

Business Wire May 19, 2022

Schrödinger to Present at Citi Biotech Virtual Co-Panel Day

Business Wire May 13, 2022

Schrödinger Reports First Quarter 2022 Financial Results

Business Wire May 4, 2022

Schrödinger to Announce First Quarter 2022 Financial Results on May 4

Business Wire April 20, 2022

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire April 19, 2022

Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List

PR Newswire April 12, 2022

Schrödinger Reports New Preclinical Data Supporting Advancement of Its Wee1 Inhibitor Program at American Association of Cancer Research 2022 Annual Meeting

Business Wire April 12, 2022

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire March 17, 2022

Schrödinger To Present New Preclinical Data From Its Wee1 Inhibitor Program At AACR Annual Meeting 2022

Business Wire March 8, 2022

Schrödinger to Present at Truist Securities Life Sciences AI Symposium - Biotech & Tools

Business Wire February 28, 2022

Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2021

Business Wire February 24, 2022

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire February 17, 2022

Schrödinger to Announce Fourth Quarter and Full-Year 2021 Financial Results on February 24

Business Wire February 10, 2022

Schrödinger to Present at SVB Leerink Virtual 11th Annual Global Healthcare Conference

Business Wire February 8, 2022